dihexa molecular weight (PNB-0408) | C27H44N4O5 | CID 125355097 Dihexa: Mechanism, Effects & Research

effects remain investigational and animal-only

It operates under the 503A compounding framework established by the Drug Quality and Security Act (DQSA) of 2013, which means it can prepare individualized prescriptions for specific patients but is not registered as a 503B outsourcing facility and is therefore not subject to the more stringent current Good Manufacturing Practice (cGMP) standards that govern 503B facilities

However, pharmacology experts agree on quality indicators in the development of synthetic biotherapeutics, and Sports Technology Labs satisfies these requirements

A place on the list is also not the same as FDA approval of BPC-157 as a drug